Odštampajte ovu stranicu
Datum kreiranja: 22.02.2014.

Slobodan Vojinović

Dodatne informacije

  • Lični podaci

  • Datum rođenja: 25.05.1964.
  • Mesto rođenja: Niš

  • Obrazovanje

  • Fakultet: Medicinski
  • Odsek / Grupa / Smer: Medicina
  • Godina diplomiranja: 1988

  • Spisak publikacija

  • Monografije i poglavlja u monografijama:

    1. Vojinović  S., Vojinović J. Optimalno i bezbedno doziranje vitamina D i analoga. U Stefanović D., Zečević R, Petronijević M. Vitamin D i analozi za zdrave kosti, za zdrav život. Monografija. Vojna štamparija Beograd 2009; Actavis trading Ltd: 99-108 (ISBN 978-86-907677-1-7 COBISS.RS-ID 156075788)
  • Knjige i udžbenici:

    1. Vojinovic Slobodan. Terapija multiple skleroze. U: Radmila Veličković-Radovanović, Srdjan Pešić, Dimitrije Jankovič . Savremena farmakoterapija. GALAKSIJA&Medicinski fakultet u Niš 2011: 359-4365. (ISBN: 978-86-6233-004-8)

    2. Vojinovic Slobodan i sar.  Osnovi neurologije za studente strukovnih studija. Udzbenik za studente strukovnih studija, Medicinski fakultet Niš 2012 ISBN-978-86-6265-002-3

    3. Vojinovic Slobodan. Najčešći poremećaji vida. U: Nešić Milkica. Neuronauke. Medicinski fakultet Niš& GALAKSIJA 2013: 109-110. ISBN 978-86-6233-029-1
  • Radovi u časopisima sa IMPACT faktorom:

    1. Stojanov A, Vojinovic S, Stojanov J, Malobabic M, Stevic M, Milosevic V, Stanojevic G. Quality of sleep and fatigue in patients with the relapsing-remitting multiple sclerosis during the coronavirus disease-2019 pandemic. Clin Neurol Neurosurg 2021 Apr 14;205:106640. doi: 10.1016/j.clineuro.2021.106640. 


    2. Montalban X, Arnold DL, Weber MS, Staikov I, Piasecka-Stryczynska K, Willmer J, Martin EC, Dangond F, Syed S, Wolinsky JS; Evobrutinib Phase 2 Study Group..... Vojinovic S. Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis. N Engl J Med. 2019 Jun 20;380(25):2406-2417. doi: 10.1056/NEJMoa1901981. Epub 2019 May 10.




    3. Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L; OPERA I and OPERA II Clinical Investigators.....Vojinovic S. Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis. N Engl J Med. 2017 Jan 19;376(3):221-234. doi: 10.1056/NEJMoa1601277. Epub 2016 Dec 21




    4. Ljubisavljevic S, Prazic A, Lazarevic M, Stojanov D, Savic D, Vojinovic S. The Rare Painful Phenomena - Chronic Paroxysmal Hemicrania-tic Syndrome as a Clinically Isolated Syndrome of the Central Nervous System. Pain Physician. 2017 Feb;20(2):E315-E322.




    5. Drulovic J, Cukic M, Grgic S, Dincic E, Raicevic R, Nadj C, Toncev G, Vojinovic S, Mesaros S, Kisic Tepavcevic D, Dujmovic I, Tadic D, Miletic-Drakulic S, Dackovic J, Kostic S, Erakovic J, Sakalas L, Savic D, Suknjaja V, Martinovic V, Maric G, Pekmezovic T. The impact of betaplus program on patient treatment satisfaction with interferon beta-1b in multiple sclerosis: Multicentric cross-sectional survey in the western Balkan countries. Mult Scler Relat Disord. 2017 Jan;11:56-61. doi: 10.1016/j.msard.2016.12.002. Epub 2016 Dec 8.




    6. Stojanov DA, Aracki-Trenkic A, Vojinovic S, Benedeto-Stojanov D, Ljubisavljevic S. Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol. Eur Radiol. 2016 Mar;26(3):807-15. doi: 10.1007/s00330-015-3879-9. Epub 2015 Jun 25.




    7. Drulovic J, Basic-Kes V, Grgic S, Vojinovic S, Dincic E, Toncev G, Kezic MG, Kisic-Tepavcevic D, Dujmovic I, Mesaros S, Miletic-Drakulic S, Pekmezovic T. The Prevalence of Pain in Adults with Multiple Sclerosis: A Multicenter Cross-Sectional Survey. Pain Med. 2015 Aug;16(8):1597-602. doi: 10.1111/pme.12731. Epub 2015 Jun 18.




    8. Vojinovic S, Savic D, Lukic S, Savic Lj, Vojinovic J. Disease relapses in multiple sclerosis can be influenced by air polution and climate seasional conditions. Vojnosanitetski pregled 2015 Jan;72(1):44-9 DOI: 10.2298/VSP140121030V




    9. Miller DH, Fox RJ, Phillips JT, Hutchinson M, Havrdova E, Kita M, Wheeler-Kingshott CA, Tozer DJ, MacManus DG, Yousry TA, Goodsell M, Yang M, Zhang R, Viglietta V, Dawson KT,…….. CONFIRM study investigators……..Vojinovic S. Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study. Neurology. 2015 Mar 17;84(11):1145-52. doi: 10.1212/WNL.0000000000001360. Epub 2015 Feb 13.




    10. Calabresi PA, Kieseier BC, Arnold DL, Balcer LJ, Boyko A, Pelletier J, Liu S, Zhu Y, Seddighzadeh A, Hung S, Deykin A,....... ADVANCE Study Investigators.......Vojinovic S. Pegylated interferon β-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study. Lancet Neurol. 2014 Jul;13(7):657-65. doi: 10.1016/S1474-4422(14)70068-7. Epub 2014 Apr 30.




    11. Ljubisavljevic S, Stojanovic I, Basic J, Vojinovic S, Stojanov D, Djordjevic G, Pavlovic D. The Role of Matrix Metalloproteinase 3 and 9 in the Pathogenesis of Acute Neuroinflammation. Implications for Disease Modifying Therapy. J Mol Neurosci. 2015 Aug;56(4):840-7. doi: 10.1007/s12031-015-0521-x. Epub 2015 Feb 22.




    12. Stojanov D, Vojinovic S, Aracki-Trenkic A, Tasic A, Benedeto-Stojanov D, Ljubisavljevic S, Vujnovic S. Imaging characteristics of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL). Bosn J Basic Med Sci. 2015 Feb 9;15(1):1-8. doi: 10.17305/bjbms.2015.247. Review.



    13. Filippi M, Rocca MA, Pagani E,...Vojinovic S, on behalf of the ALLEGRO Study Group. Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage. J Neurol Neurosurg Psychiatry. 2013 Sep 12. doi: 10.1136/jnnp-2013-306132 IF 5.144 M21

    14. Cohen JA, Coles AJ, Arnold DL, Confavreux C, … and CARE-MS I investigators .. Vojinović S.  Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial. Lancet. 2012 Nov 24;380(9856):1819-28. doi: 10.1016/S0140-6736(12)61769-3. IF 39.06 M21

    15. Gold R, Kappos L, Arnold DL, Bar-Or A, ….. DEFINE Study Investigators…. Vojinovic S... Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med. 2012 Sep 20;367(12):1098-107. IF 51.658 M21

    16. Fox RJ, Miller DH, Phillips JT, …CONFIRM Study Investigators …. Vojinovic S…... Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis. N Engl J Med. 2012 Sep 20;367(12):1087-97. IF 51.68 M21

    17. Comi G, Jeffery D, Kappos L, Montalban X….ALLEGRO Study Group… Vojinovic S ... Placebo-controlled trial of oral laquinimod for multiple sclerosis. N Engl J Med. 2012 Mar 15; 366(11): 1000-9. doi: 10.1056/NEJMoa1104318. IF 51.658 M21

    18. Garren H, Robinson WH, Krasulová E, Havrdová E,….BHT-3009 Study Group…Vojinovic  S…. Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis. Ann Neurol. 2008 May 63(5):611-20. IF 9.081 M21

    19. Ljubisavljevic S, Stojanovic I, Cvetkovic T, Vojinovic S, Stojanov D, Stojanovic D, Stefanovic N, Pavlovic D. Erythrocytes' antioxidative capacity as a potential marker of oxidative stress intensity in neuroinflammation. J Neurol Sci. 2013 Nov 13. pii: S0022-510X(13)03019-0. doi: 10.1016/j.jns.2013.11.006 IF 20199 M22

    20. Živković M, Životić I, Dinčić E, Stojković L, Vojinović S, Stanković A.The glutathione S-transferase T1 deletion is associated with susceptibility to multiple sclerosis. J Neurol Sci. 2013 Nov 15;334(1-2):6-9. doi: 10.1016/j.jns.2013.07.001. Epub 2013 Aug 9. IF 2.413 M22

    21. Ljubisavljevic S, Stojanovic I, Vojinovic S, Milojkovic M, Dunjic O, Stojanov D, Pavlovic D. Association of serum bilirubin and uric acid levels changes during neuroinflammation in patients with initial and relapsed demyelination attacks.  Metab Brain Dis. 2013 Dec;28(4):629-38. doi: 10.1007/s11011-013-9409-z IF 2.680 M22

    22. Ljubisavljevic S, Stojanovic I, Vojinovic S, Stojanov D, Stojanovic S, Cvetkovic T, Savic D, Pavlovic D. The patients with clinically isolated syndrome and relapsing remitting multiple sclerosis show different levels of advanced protein oxidation products and total thiol content in plasma and CSF. Neurochem Int. 2013 Jun;62(7):988-97. doi: 10.1016/j.neuint.2013.02.025. IF2.875 M22

    23. Stojanovic I, Vojinovic S, Ljubisavljevic S, Pavlovic R, Basic J, Pavlovic D, Ilic A, Cvetkovic T, Stukalov M. INF-β1b therapy modulates L-arginine and nitric oxide metabolism in patients with relapse remittent multiple sclerosis. J Neurol Sci. 2012 Dec 15;323(1-2):187-92. doi: 10.1016/j.jns.2012.09.014. IF 2.413 M22

    24. Kostic M, Dzopalic T, Zivanovic S, Zivkovic N, Cvetanovic A, Stojanovic I, Vojinovic S, Marjanovic G, Savic V, Colic M. IL-17 And Glutamte Excitotoxicity In The Pathogenesis Of Multiple Sclerosis. Scand J Immunol. 2014 Jan 2. doi: 10.1111/sji.12147 IF 2.199 M23

    25. Ljubisavljevic S, Stojanovic I, Cvetkovic T, Vojinovic S, Stojanov D, Stojanovic D, Bojanic V, Stokanovic D, Pavlovic D. Glutathione homeostasis disruption of erythrocytes, but not glutathione peroxidase activity change, is closely accompanied with neurological and radiological scoring of acute CNS inflammation. Neuroimmunomodulation. 2014;21(1):13-20. doi: 10.1159/000355040 IF 1.835 M23

    26. Ljubisavljevic S, Stojanovic I, Vojinovic S, Stojanov D, Stojanovic S, Kocic G, Savic D, Cvetkovic T, Pavlovic D. Cerebrospinal fluid and plasma oxidative stress biomarkers in different clinical phenotypes of neuroinflammatory acute attacks. Conceptual accession: from fundamental to clinic. Cell Mol Neurobiol. 2013 Aug;33(6):767-77. doi: 10.1007/s10571-013-9944-5 IF 2.29 M23

    27. Ljubisavljevic S, Stojanovic I, Pavlovic D, Milojkovic M, Vojinovic S, Sokolovic D, Stevanovic I. Correlation of nitric oxide levels in the cerebellum and spinal cord of experimental autoimmune encephalomyelitis rats with clinical symptoms. Acta Neurobiol Exp (Wars). 2012;72(1):33-9. IF 1.98 M23

    28. Stojanović I, Ljubisavljević S, Stevanović I, Pavlović R, Cvetković T, Djordjević V, Pavlović D, Vojinović S, Basić J. Nitric oxide-mediated signalization and nitrosative stress in neuropathology. J Med Biochem 2012;31: 295-300

    29. Savić D, Vojinović S, Spasić M, Perič Z, Lukić S. Syringomyelia in demyelinating disease of the central nervous system: report of two cases. Srp Arh Celok Lek. 2011 Sep-Oct;139(9-10):657-60 IF0.19 M23

    30. Lukic S, Spasic M, Peric Z, Savic D, Vojinovic S, Stojanov D, Ljubisavljević S. A case of complex arteriovenous malformation with skull destruction presented in sixth decade of life. Neurol Sci. 2011 Jun;32(3):479-82. doi: 10.1007/s10072-010-0472-5. IF 1.315 M23
  • Radovi u ostalim časopisima:

    1. Vojinovic S, Vojinovic J, Cosic V, Savic V.: Effects of alfacalcidol therapy on serum cytokine levels in patients with multiple sclerosis. Srp Arh Celok Lek. 2005 Dec;133 Suppl 2:124-8

    2.  Vojinović  S, Vojinović J, B. Kamenov, D. Vojinović, D. Gocić-Stanković: Subpopulacije T- limfocita periferne krvi kod multiple skleroze-zavisnost od kliničke forme bolesti. Srp.arh.celok.lek. 1994; 122 (suppl): 64-66.

    3. Vojinović S, D. Vojinović: Savremeni principi dijagnoze multiple skleroze. Acta Fac. Med. Naiss. 1999; 16(3): 167-172.

    4. Savić D, Vojinović S, Lukić S, Savić Lj. Clinical and neurophysiological features in patients presenting clinically isolated syndomes suggestive on multiple sclerosis. Acta Fac Med Naiss. 2010; 27 (2): 69-74

    5. Vojinović S., Vojinović J, Ćosić V, Savić V. Uticaj alfakalcidola na nivo citokina kod pacijenata sa multiplom sklerozom. Aktuelnosti iz neurologije, psihijatrije i graničnih područja, vol. 12, br. 1-2, str. 77-85, 2004

    6. Vojinović Slobodan. Nove terapije koje modifikuju prirodni tok multiple skleroze. Simpozijum: Novine u terapiji neuroloških oboljenja Kragujevac 2012: 115-126 ISBN978-86-7084-051-5

    7. Vojinović Slobodan.  Oralne terapije u multiploj sklerozi. IX/XV Kongres neurologa sa međunarodnim učešćem Novembar 2013 Beograd (elektronsko izdanje)

    8. Vojinović S. Značaj vitamina D za nastanak i progresiju multiple skleroze. Zbornik sažetaka VII/XIII Kongres neurolga Srbije sa međunarodnim učešćem 2008 Kragujevac: str 70
  • Radovi na naučnim skupovima međunarodnog značaja:

    Vojinovic, S.,Ilic, A. Treatment options of spasticity in multiple sclerosis patients. Conference: 14th Congress of European-Federation-of-Neurological-Societies Geneva, SWITZERLAND  SEP, 2010 EUROPEAN JOURNAL OF NEUROLOGY  Volume: 17   Special Issue: SI   Supplement: 3   Pages: 489-489


    Stojanov, D.; Ljubisavljević S.; Vojinović, S; Stojanović, I. Association of MR features and clinical presentation, levels of advanced oxidation protein products and total thiol content in plasma and CSF in patients with clinically isolated syndrome and relapsing remitting multiple sclerosis. Conference: 37th ESNR Annual Meeting, Frankfurt, GERMANY 28 sep-01 oct 2013 NEURORADIOLOGY Volume: 55 Supplement 1 Pages:35-35


    Ljubisavljevic, S.; Stojanovic, I.; Pavlovic, D., Vojinovic S et al. The influence of aminoguanidine and N-acetyl-L-cysteine on oxidative and nitrosative stress in brain of EAE rats. Conference: 21st Meeting of the European-Neurological-Society, Lisbon, PORTUGAL MAY 28-31, 2011 JOURNAL OF NEUROLOGY  Volume: 258   Supplement: 1   Pages:209-209


    Dincic, E.; Popovic, S.; Nadj, C., Vojinovic S. et al. Timing of birth and risk of multiple sclerosis in Serbian population. Conference: 23rd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis/12th Annual Conference of Rehabilitation in MS  Prague, CZECH REPUBLIC  OCT 11-14, 2007 MULTIPLE SCLEROSIS  Volume: 13   Supplement: 2   Pages: S92-S92


    Richard Gammans, Fredrik Barkhof, Jelena Drulovic,..Vojinovic S... MN-166-CL-001 Study group. Clinical effect of the neuroprotectant MN-166 in relapsing multiple sclerosis: year 2 data.Multiple Sclerosis 2008 Vol 14 Suppl 1: S43


    Dincic E,  Popovic S,  Nadj C,   Toncev G, Vojinovic S, Obradovic D, Raicevic R: Timing of birth and risk of multiple sclerosis in Serbian population. MULTIPLE SCLEROSIS , (2007 ) vol.13 br. str. S92 -S92


    Ilic A, Vojinovic S, Stojanovic I, et al. Efect of interferon-beta-1b therapy on nitric oxide (nitrite/nitrate) serum level in patients with relapsing-remitting multiple sclerosis. MULTIPLE SCLEROSIS  2006 Vol 12   Pages: S200-S200  Suppl. 1


    Ilic A, Jolic M, Djuric S, Vojinovic S et al. Pattern electroretinogram: importance for visual acuity recovery assessment after optic neuritis in multiple sclerosis patients. JOURNAL OF THE NEUROLOGICAL SCIENCES  2005  Vol 238   Pages: S230-S231 Suppl. 


    Vojinovic S, Vojinovic J, Cosic V, et al. Effects of alfacalcidol on serum nitric oxide metabolites in relapsing-remitting multiple sclerosis. JOURNAL OF THE NEUROLOGICAL SCIENCES 2005  Vol 238   Pages: S254-S254  Suppl


    Vojinovic S, Vojinovic J, Cosic V, et al. Effects of alfacalcidol on cytokine levels in multiple sclerosis. MULTIPLE SCLEROSIS 2004  Vol10   Issue:7032   Pages: S260-S260  Suppl. 2  


    Vojinović S., S. Lukić: Multiple sclerosis with late onset. Proceedings of 17th Congress ECTRIMS – European Committe for Treatment and Research in Multiple Sclerosis. September 2001, Dublin, Ireland.


    Zvezdanović L., Živković M., Vojinović S., Ćosić V., Stanišić S., Lalić J., Djordjević B.V.: Superoxid dismutase and glutathione peroxidase activities in patients with meningiris, brain ishemia and multiple sclerosis.Clin Chem Lab Med 2001; Vol 39; Suppl.: S122.


    L.Blagojević, Z. Todorović, S. Vojinović: Electroneurographical findings in varnishers before and after vitaminotherapy. Br J Clin Pharmacol 2000; 50 (1) Suppl: 114.


    S. Vojinović, D. Gocić-Stanković: A silent form of multiple sclerosis. Neuroradiology Sept. 1996; Vol. 38 (Suppl. 2): S 98 
  • Radovi na domaćim naučnim skupovima:

    1. Vojinovic S. Nove terapije koje modifikuju tok multiple skleroze – oralni lekovi.  VIII/IX Kongres neurologa sa međunarodnim učešćem Kopaonik 2011: 22

    2. Vojinović S. Nove terapije koje modifikuju tok multiple skleroze. VIII/IX Kongres neurologa sa međunarodnim učešćem Kopaonik 2011: 317


    3. Ilić A., Vojinović S., Stojanov D., Stošić M. Betaferon u terapiji relapsno-remitentne multiple skleroze – petogodišnje praćenje. VIII/IX Kongres neurologa sa međunarodnim učešćem Kopaonik 2011: 127




    4. Ljubisavljević S., Stojanović I, Stojanov D, Vojinović S, Pavlović D. Patogenetski aspekti intracelularnog oksidativnog stresa u različitim kliničkim fenotipovima inflamacije CNS. . IX/XV Kongres neurologa sa međunarodnim učešćem Novembar 2013 Beograd: 80




    5. Vojinović S., Ilić A., Stojanović I., Zvezdanović L., Djordjević V. Terapija IFNbeta smanjuje serumske nivoe nitrita/nitrata (NO) kod bolesnika sa relapsno-remitentnom multiplom sklerozom. Zbornik sažetaka VII/XIII Kongres neurolga Srbije sa međunarodnim učešćem 2008 Kragujevac: str 236




    6. Ilić A., Vojinović S., Stojanović I., Zvezdanović L., Djordjević V. Uticaj terapije interferonom beta-1b na aktivnost katalaze kod bolesnika sa relapsno-remitentnom multiplom sklerozom. Zbornik sažetaka VII/XIII Kongres neurolga Srbije sa međunarodnim učešćem 2008 Kragujevac: str 224




    7. S. Vojinović, D. Gocić-Stanković: Multipla skleroza kasnog početka. V Kongres neurologa Jugoslavije, 31.maj-3.jun 2000, Zlatibor, knjiga sažetaka str. 125




    8. D. Gocić-Stanković, S. Vojinović: rekombinovani interferon-beta u tretmanu multiple skleroze. V Kongres neurologa Jugoslavije, 31.maj-3.jun 2000, Zlatibor, knjiga sažetaka str. 119.




    9. S. Vojinović, D. Vojinović: Oligosimptomatske angioektazije cerebralnih krvnih sudova. V Kongres neurologa Jugoslavije, 31.maj-3.jun 2000, Zlatibor, knjiga sažetaka str.77.




    10. S. Minić, D. Vojinović, S. Vojinović: Problemi terapije Parkinsonove bolesti. V Kongres neurologa Jugoslavije, 31.maj-3.jun 2000, Zlatibor, knjiga sažetaka str.141.




    11. S. Vojinović, J. Vojinović, B. Kamenov, D. Gocić-Stanković: Markeri imunofenotipizacije periferne krvi kod obolelih od multiple skleroze. III Kongres neurologa Jugoslavije i I Kongres Jugoslovenskog društva za neuronauke, maj Beograd, knjiga sažetaka str. 34.




    12. Z. Perić, D. Vojinović, S. Vojinović: Kriptogene neuropatije-kako ih definisati?. III Kongres neurologa Jugoslavije i I Kongres Jugoslovenskog društva za neuronauke, maj 1993, Beograd, knjiga sažetaka str.229.




    13. S. Vojinović, Z. Perić, D. Vojinović, S. Ristić: Komparativna analiza kliničkih karakteristika ALS i ALS-sindroma. III Kongres neurologa Jugoslavije i I Kongres Jugoslovenskog društva za neuronauke, maj 1993, Beograd, knjiga sažetaka str.466.




    14. D. Lukić, M. Živković, S. Vojinović, M. Veličković, S. Ristić: Alterni sindromi moždanog stabla (epidemiološki aspekti). III Kongres neurologa Jugoslavije i I Kongres Jugoslovenskog društva za neuronauke, maj 1993, Beograd, knjiga sažetaka str.147.




    15. D. Vojinović, D. Lukić, M. Živković, S. Vojinović: Alterni sindromi-klinička evaluacija. III Kongres neurologa Jugoslavije i I Kongres Jugoslovenskog društva za neuronauke, maj 1993, Beograd, knjiga sažetaka str.248.




    16. D. Vojinović, D. Lukić, M. Živković, S. Vojinović: Spontani subduralni hematomi u diferencijalnoj dijagnozi ishemičnog inzulta. . III Kongres neurologa Jugoslavije i I Kongres Jugoslovenskog društva za neuronauke, maj 1993, Beograd, knjiga sažetaka str.251.




    17. D. Vojinović, S. Vojinović, D. Gocić-Stanković: Guillain-Barre sindrom: protein manifestacije i odgovor na terapiju. Godišnji sastanak udruženja alergologa i kliničkih imunologa Jugoslavije, novembar 1993, Niš, Zbornik radova, str. 146.




    18. D. Vojinović, S. Vojinović; Miastenični sindrom kao vid paraneoplastičnog ispoljavanja. Godišnji sastanak udruženja alergologa i kliničkih imunologa Jugoslavije, novembar 1993, Niš, Zbornik radova, str. 149.




    19. D. Vojinović, D. Gocić-Stanković, S. Vojinović: Amnesia can facilitate memory performance. Postgraduate course and 31st International neuropsychiatric symposium, May-June 1991, Pula, Proceedings, p 130.




    20. D. Vojinović, S. Vojinović, G. Đorđević, S. Ristić: Komparativna analiza kliničkih manifestacija ishemičnog inzulta, CT mozga i Doppler sonografije magistralnih krvnih sudova. IV Kongres neurologa Jugoslavije, maj 1996, Niška banja. Zbornik sažetaka str.86.




    21. S. Vojinović, D. Vojinović, D. Gocić-Stanković: Retrobulbarni neuritis-problemi evaluacije. IV Kongres neurologa Jugoslavije, maj 1996, Niška banja. Zbornik sažetaka str.121.




    22. D. Vojinović, S. Minić, D. Gocić-Stanković, M. Rančić, S. Vojinović: Psihoorganski sindrom parkinsonizma. IV Kongres neurologa Jugoslavije, maj 1996, Niška banja. Zbornik sažetaka str.164.




    23. S. Ristić, M. Spasić, S. Vojinović, V. Kostić, D. Vojinović: Naša iskustva u lečenju serijskih epileptičkih napada i epileptičkih statusa. IV Kongres neurologa Jugoslavije, maj 1996, Niška banja. Zbornik sažetaka str.174.




    24. S. Vojinović, D. Vojinović, N. Vukašinović: Akutno nastala koma uslovljena meningitisom-prikaz slučaja. . IV Kongres neurologa Jugoslavije, maj 1996, Niška banja. Zbornik sažetaka str.254.




    25. S. Vojinović, D. Vojinović, V. Kostić: Cervikalne kompresije-problemi diferencijalne dijagnoze. IV Kongres neurologa Jugoslavije, maj 1996, Niška banja. Zbornik sažetaka str. 255-256.




    26. S. Vojinović, D. Vojinović, G. Đorđević: Problemi dijagnoze paraplegija uslovljenih sekundarnim depozitima. IV Kongres neurologa Jugoslavije, maj 1996, Niška banja. Zbornik sažetaka str. 254-255.



    27. D. Gocić-Stanković, A. Ilić, S. Vojinović: Memorijski deficit i nivo vazopresina-A kod demencije Alzheimer-ovog tipa. II Kongres Jugoslovenskog društva za neuronauke, jun 1995, Sveti Stefan-Kotor, Zbornik sažetaka str.125.
Poslednji put izmenjeno četvrtak, 16 septembar 2021 20:53
Tagovano
Objavljeno u Medicinski fakultet